BIO Deferred Long Term Liab vs Capital Stock Analysis

BKYI Stock

USD 1.07 0.03 2.73%

BIO Key financial indicator trend analysis is way more than just evaluating BIO Key International prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BIO Key International is a good investment. Please check the relationship between BIO Key Deferred Long Term Liab and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Deferred Long Term Liab vs Capital Stock

Deferred Long Term Liab vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BIO Key International Deferred Long Term Liab account and Capital Stock. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between BIO Key's Deferred Long Term Liab and Capital Stock is -0.1. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of BIO Key International, assuming nothing else is changed. The correlation between historical values of BIO Key's Deferred Long Term Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of BIO Key International are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Deferred Long Term Liab i.e., BIO Key's Deferred Long Term Liab and Capital Stock go up and down completely randomly.

Correlation Coefficient

-0.1

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Most indicators from BIO Key's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BIO Key International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

The BIO Key's current Tax Provision is estimated to increase to about 128.5 K, while Selling General Administrative is projected to decrease to under 5.1 M.

	2021	2022	2023	2024 (projected)
Interest Expense	18K	30.0K	218.3K	207.4K
Depreciation And Amortization	514.1K	546.0K	590.1K	573.1K

Interest Expense Depreciation And Amortization

BIO Key fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Non Current Liabilities Total	Other Assets
Total Assets		0.24	0.16	-0.02	0.99	0.24	-0.68	-0.29	-0.11	0.67	0.75	-0.27	0.66	-0.5	0.33	0.38	0.59	0.47	-0.06	-0.11	0.89	-0.06	-0.52	0.65	-0.37	0.39
Short Long Term Debt Total	0.24		-0.15	0.03	0.23	0.01	0.22	0.13	0.01	-0.2	0.48	-0.28	-0.2	-0.2	0.48	-0.08	0.48	-0.09	-0.06	-0.37	-0.02	0.23	-0.11	0.35	-0.41	0.33
Other Current Liab	0.16	-0.15		0.61	0.06	0.29	0.16	-0.67	0.35	-0.11	0.25	0.05	-0.11	-0.68	0.14	0.37	-0.06	0.64	0.61	0.51	0.08	0.11	-0.75	0.32	-0.31	0.26
Total Current Liabilities	-0.02	0.03	0.61		-0.16	0.55	0.24	-0.68	0.72	-0.09	-0.11	-0.02	-0.08	-0.56	-0.25	0.39	-0.05	0.6	0.96	0.49	0.07	0.77	-0.59	0.14	-0.15	-0.16
Total Stockholder Equity	0.99	0.23	0.06	-0.16		0.15	-0.7	-0.18	-0.21	0.66	0.76	-0.26	0.65	-0.41	0.37	0.32	0.6	0.37	-0.2	-0.19	0.86	-0.18	-0.43	0.63	-0.35	0.41
Property Plant And Equipment Net	0.24	0.01	0.29	0.55	0.15		-0.37	-0.61	0.05	0.51	-0.11	-0.23	0.53	-0.48	-0.34	0.26	-0.27	0.58	0.56	0.47	0.41	0.53	-0.5	-0.19	0.11	-0.14
Net Debt	-0.68	0.22	0.16	0.24	-0.7	-0.37		0.23	0.35	-0.98	-0.13	0.14	-0.98	0.19	0.11	-0.16	-0.06	-0.35	0.2	-0.01	-0.86	0.19	0.19	-0.08	0.04	0.04
Retained Earnings	-0.29	0.13	-0.67	-0.68	-0.18	-0.61	0.23		-0.42	-0.3	-0.05	0.19	-0.3	0.83	-0.07	-0.49	0.13	-0.98	-0.74	-0.75	-0.42	-0.29	0.84	-0.21	0.35	0.14
Accounts Payable	-0.11	0.01	0.35	0.72	-0.21	0.05	0.35	-0.42		-0.29	-0.1	0.01	-0.29	-0.29	0.0	0.11	0.25	0.33	0.63	0.35	-0.09	0.44	-0.35	0.31	-0.21	-0.3
Cash	0.67	-0.2	-0.11	-0.09	0.66	0.51	-0.98	-0.3	-0.29		0.08	-0.15	1.0	-0.24	-0.2	0.23	0.0	0.4	-0.07	0.05	0.87	-0.01	-0.24	0.03	0.0	-0.08
Non Current Assets Total	0.75	0.48	0.25	-0.11	0.76	-0.11	-0.13	-0.05	-0.1	0.08		-0.21	0.07	-0.44	0.61	0.1	0.68	0.2	-0.16	-0.2	0.37	-0.24	-0.47	0.71	-0.46	0.77
Non Currrent Assets Other	-0.27	-0.28	0.05	-0.02	-0.26	-0.23	0.14	0.19	0.01	-0.15	-0.21		-0.15	0.11	-0.09	-0.16	-0.15	-0.24	-0.06	-0.19	-0.25	-0.07	0.09	-0.19	-0.21	-0.02
Cash And Short Term Investments	0.66	-0.2	-0.11	-0.08	0.65	0.53	-0.98	-0.3	-0.29	1.0	0.07	-0.15		-0.24	-0.21	0.22	0.0	0.4	-0.06	0.06	0.87	0.0	-0.25	0.01	0.01	-0.08
Common Stock Total Equity	-0.5	-0.2	-0.68	-0.56	-0.41	-0.48	0.19	0.83	-0.29	-0.24	-0.44	0.11	-0.24		-0.38	-0.36	-0.14	-0.86	-0.55	-0.43	-0.43	-0.17	0.97	-0.44	0.71	-0.28
Common Stock Shares Outstanding	0.33	0.48	0.14	-0.25	0.37	-0.34	0.11	-0.07	0.0	-0.2	0.61	-0.09	-0.21	-0.38		0.03	0.44	0.14	-0.29	-0.2	0.04	-0.36	-0.34	0.55	-0.65	0.29
Inventory	0.38	-0.08	0.37	0.39	0.32	0.26	-0.16	-0.49	0.11	0.23	0.1	-0.16	0.22	-0.36	0.03		-0.09	0.51	0.33	0.02	0.46	0.42	-0.37	0.15	-0.09	-0.02
Other Current Assets	0.59	0.48	-0.06	-0.05	0.6	-0.27	-0.06	0.13	0.25	0.0	0.68	-0.15	0.0	-0.14	0.44	-0.09		0.01	-0.11	-0.23	0.36	-0.13	-0.16	0.88	-0.4	0.24
Other Stockholder Equity	0.47	-0.09	0.64	0.6	0.37	0.58	-0.35	-0.98	0.33	0.4	0.2	-0.24	0.4	-0.86	0.14	0.51	0.01		0.67	0.69	0.57	0.21	-0.87	0.35	-0.4	-0.04
Total Liab	-0.06	-0.06	0.61	0.96	-0.2	0.56	0.2	-0.74	0.63	-0.07	-0.16	-0.06	-0.06	-0.55	-0.29	0.33	-0.11	0.67		0.66	0.07	0.66	-0.6	0.11	-0.1	-0.22
Property Plant And Equipment Gross	-0.11	-0.37	0.51	0.49	-0.19	0.47	-0.01	-0.75	0.35	0.05	-0.2	-0.19	0.06	-0.43	-0.2	0.02	-0.23	0.69	0.66		0.05	0.06	-0.47	0.0	0.08	-0.3
Total Current Assets	0.89	-0.02	0.08	0.07	0.86	0.41	-0.86	-0.42	-0.09	0.87	0.37	-0.25	0.87	-0.43	0.04	0.46	0.36	0.57	0.07	0.05		0.06	-0.44	0.45	-0.21	0.01
Short Term Debt	-0.06	0.23	0.11	0.77	-0.18	0.53	0.19	-0.29	0.44	-0.01	-0.24	-0.07	0.0	-0.17	-0.36	0.42	-0.13	0.21	0.66	0.06	0.06		-0.16	-0.12	0.14	-0.27
Common Stock	-0.52	-0.11	-0.75	-0.59	-0.43	-0.5	0.19	0.84	-0.35	-0.24	-0.47	0.09	-0.25	0.97	-0.34	-0.37	-0.16	-0.87	-0.6	-0.47	-0.44	-0.16		-0.45	0.62	-0.3
Net Receivables	0.65	0.35	0.32	0.14	0.63	-0.19	-0.08	-0.21	0.31	0.03	0.71	-0.19	0.01	-0.44	0.55	0.15	0.88	0.35	0.11	0.0	0.45	-0.12	-0.45		-0.54	0.22
Non Current Liabilities Total	-0.37	-0.41	-0.31	-0.15	-0.35	0.11	0.04	0.35	-0.21	0.0	-0.46	-0.21	0.01	0.71	-0.65	-0.09	-0.4	-0.4	-0.1	0.08	-0.21	0.14	0.62	-0.54		-0.31
Other Assets	0.39	0.33	0.26	-0.16	0.41	-0.14	0.04	0.14	-0.3	-0.08	0.77	-0.02	-0.08	-0.28	0.29	-0.02	0.24	-0.04	-0.22	-0.3	0.01	-0.27	-0.3	0.22	-0.31

Click cells to compare fundamentals

BIO Key Account Relationship Matchups

BIO Key fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.5M	22.5M	17.8M	11.9M	4.5M	4.3M
Other Current Liab	686.9K	490.9K	770.4K	984.5K	1.2M	963.2K
Total Current Liabilities	4.4M	1.9M	2.0M	4.6M	3.2M	3.1M
Total Stockholder Equity	(2.3M)	20.3M	15.6M	7.1M	1.1M	1.0M
Property Plant And Equipment Net	662.0K	569.1K	323.3K	304.8K	257.1K	226.5K
Net Debt	2.7M	(16.3M)	(7.5M)	(414.1K)	(146.1K)	(138.8K)
Retained Earnings	(89.7M)	(99.5M)	(104.6M)	(114.8M)	(125.0M)	(118.8M)
Accounts Payable	919.3K	244.2K	427.8K	1.1M	1.3M	667.1K
Cash	79.0K	17.0M	7.8M	2.6M	511.4K	485.8K
Non Current Assets Total	1.1M	3.6M	3.8M	2.5M	1.9M	1.8M
Non Currrent Assets Other	240.2K	174.0K	370.7K	437.8K	229.8K	218.3K
Cash And Short Term Investments	591.8K	17.5M	7.8M	2.6M	511.4K	485.8K
Common Stock Total Equity	769.0	1.4K	1.4K	782.0	703.8	668.61
Common Stock Shares Outstanding	98.8K	261.2K	432.9K	450.0K	560.3K	391.0K
Liabilities And Stockholders Equity	2.5M	22.5M	17.8M	11.9M	4.5M	4.3M
Inventory	429.1K	330.9K	4.9M	4.8M	445.7K	657.9K
Other Current Assets	108.4K	201.5K	216.0K	342.7K	364.2K	346.0K
Other Stockholder Equity	87.4M	119.8M	120.2M	122.0M	126.0M	132.4M
Total Liab	4.8M	2.2M	2.2M	4.9M	3.5M	4.7M
Property Plant And Equipment Gross	662.0K	569.1K	323.3K	304.8K	1.4M	1.4M
Total Current Assets	1.4M	18.9M	14.0M	9.4M	2.6M	5.0M
Short Term Debt	2.4M	466.3K	177.2K	2.9M	176.6K	167.7K
Common Stock	1.4K	782.0	786.0	919.0	103.0	97.85
Net Receivables	236.9K	903.5K	1.1M	1.6M	1.3M	1.6M
Non Current Liabilities Total	390.5K	309.2K	154.3K	210.0K	240.1K	228.1K
Accumulated Other Comprehensive Income	(690.5K)	(772.3K)	0.0	(242.6K)	22.8K	24.0K
Other Assets	240.2K	174.0K	370.7K	1.0	0.9	0.86
Property Plant Equipment	148.6K	662.0K	569.1K	323.3K	371.8K	240.4K
Current Deferred Revenue	359.2K	657.3K	565.4K	462.4K	415.0K	394.2K
Intangible Assets	228.2K	1.6M	1.3M	1.8M	1.4M	2.6M
Deferred Long Term Liab	319.2K	231.5K	165.3K	249.0K	286.4K	248.3K
Net Tangible Assets	3.5M	(2.5M)	17.5M	13.0M	14.9M	15.7M
Capital Surpluse	80.8M	85.6M	87.4M	119.8M	137.8M	88.3M
Net Invested Capital	(29.7K)	20.6M	15.6M	9.1M	1.4M	1.3M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:

How To Invest In BIO

Details

Is BIO Stock a good investment?

Details

What is BIO Key's Net Worth?

Details

Largest Security & Protection Services Companies

View

Largest Information Technology Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(8.66)

Revenue Per Share

6.323

Quarterly Revenue Growth

(0.41)

Return On Assets

(0.56)

Return On Equity

(4.58)

The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BIO Deferred Long Term Liab vs Capital Stock Analysis

Deferred Long Term Liab vs Capital Stock

Deferred Long Term Liab vs Capital Stock Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Capital Stock

BIO Key fundamental ratios Correlations

BIO Key Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BIO Key fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Common Stock	+ 0.97	Common Stock Total Equity
Total Liab	+ 0.96	Total Current Liabilities
Total Current Assets	+ 0.89	Total Assets
Net Receivables	+ 0.88	Other Current Assets

Other Stockholder Equity	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Common Stock	- 0.87	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Common Stock Total Equity
Total Current Assets	- 0.86	Net Debt